Clinical Trials Logo

Fracture of Neck of Femur clinical trials

View clinical trials related to Fracture of Neck of Femur.

Filter by:
  • None
  • Page 1

NCT ID: NCT05233072 Recruiting - Clinical trials for Fracture of Neck of Femur

Prognostic Impact of Neopterin on Resumption of Walking After a Fracture of the Upper Neck of the Femur in the Elderly

MAMI
Start date: May 16, 2022
Phase: N/A
Study type: Interventional

Society faces a major challenge with the management of the health and socio-economic burden caused by acute physical stress in the older population (>75 years). In particular, hip fracture (HF) represents a major health care preoccupation, affecting 1.6 M patients worldwide, resulting in a significant drop of life quality and autonomy. Nowadays, this trauma is still associated with a poor outcome of 20-30% one-year mortality in the elderly. This emphasizes the value of assessing biological factors that may predict clinical outcome after HF. The preliminary work pinpoints a central role of neopterin in loss of autonomy and death. Using HF as an acute stress model that accelerates the progressive course of aging, the aim is to validate neopterin as a predictive biomarker of pernicious clinical outcomes.

NCT ID: NCT04017403 Recruiting - Knee Osteoarthritis Clinical Trials

Probiotics Attenuate Postoperative Cognition Decline

Start date: December 15, 2019
Phase: N/A
Study type: Interventional

The aim of this study was to evaluate whether perioperative probiotics can reduce the incidence of postoperative cognitive dysfunction and postoperative delirium.

NCT ID: NCT00307905 Withdrawn - Pain Clinical Trials

TRAUMEEL for Pain After Fracture of Neck of Femur

Start date: January 2011
Phase: Phase 3
Study type: Interventional

We hypothesize that Traumeel S is more effective than placebo in reducing 48-hour mean cumulative morphine consumption in patients scheduled for surgical correction of fracture of neck of hip. 224 patients, meeting all inclusion and none of exclusion criteria, will be enrolled in the trial. Patients will be randomized to receive either intraoperative injection and post operative oral Traumeel S Tablets or placebo injection (normal saline) and indistinguishable oral placebo tablets. Baseline measurements of relevant outcome measures will taken preoperatively. Immediately after surgery, patients will receive an initial dose of morphine of 0.1mg/kg body weight. Patients will take the oral study medication for 21 days. Every four hours after surgery, patients will be asked to grade their pain on an NRS. Subsequent doses of morphine will be calculated based upon the patient's weight and current NRS, according to a preplanned scheme. Patients will be permitted to request additional morphine, beyond their calculated dose.